| Literature DB >> 31465302 |
Colt A Egelston1, Christian Avalos1, Travis Y Tu1, Anthony Rosario1, Roger Wang1, Shawn Solomon1, Gayathri Srinivasan1, Michael S Nelson2, Yinghui Huang1, Min Hui Lim1, Diana L Simons1, Ting-Fang He1, John H Yim3, Laura Kruper3, Joanne Mortimer4, Susan Yost4, Weihua Guo1, Christopher Ruel5, Paul H Frankel5, Yuan Yuan4, Peter P Lee1.
Abstract
CD8+ tumor-infiltrating lymphocytes (TILs) correlate with relapse-free survival (RFS) in most cancer types, including breast cancer. However, subset composition, functional status, and spatial location of CD8+ TILs in relation to RFS in human breast tumors remain unclear. Spatial tissue analysis via quantitative immunofluorescence showed that infiltration of CD8+ T cells into cancer islands was more significantly associated with RFS than CD8+ T cell infiltration into either tumor stroma or total tumor. Localization into cancer islands within tumors is mediated by expression of the integrin CD103, which is a marker for tissue-resident memory T cells (TRMs). Analysis of fresh tumor samples revealed that CD8+ TRMs are functionally similar to other CD8+ TILs, suggesting that the basis of their protective effect is their spatial distribution rather than functional differences. Indeed, CD103+ TRMs, as compared with CD103-CD8+ TILs, are enriched within cancer islands, and CD8+ TRM proximity to cancer cells drives the association of CD8+ TIL densities with RFS. Together, these findings reveal the importance of cancer island-localized CD8+ TRMs in surveillance of the breast tumor microenvironment and as a critical determinant of RFS in patients with breast cancer.Entities:
Keywords: Breast cancer; Immunology; Oncology; T cells
Year: 2019 PMID: 31465302 PMCID: PMC6795408 DOI: 10.1172/jci.insight.130000
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708